December 23, 2011
MRI gives a ‘better’ view of heart
disease
A
major clinical trial funded by us has shown that a magnetic
resonance imaging (MRI) scan is a better tool for diagnosing
suspected coronary heart disease (CHD) than the most commonly used
alternative.
The research was carried out at Leeds General
Infirmary and could change how people, who may have
CHD, are assessed by doctors. It could
mean these people do not have to undergo an invasive examination or
a scan involving radiation.
The five-year study, led by Dr John Greenwood from the
University of Leeds, received a £1.3 million grant from us. This
allowed the researchers to recruit over 750 patients with CHD and,
for the first time, compare how effective
MRI is against the current ‘gold standard’ diagnostic
tests.
Professor Peter Weissberg, our Medical Director, said: “For
patients suffering with chest pains, there are a number of tests
that can be used to decide whether their symptoms are due to
coronary heart disease or not. This research shows that an
MRI scan is better than the most commonly used
alternative -
a SPECT scan using a radioactive tracer.
“MRI has the additional advantage that it doesn’t involve
radiation. At present, not all hospitals have the
expertise to undertake such scans but these findings
provide clear evidence that MRI should be more widely used in the
future.”
The researchers hope their study will lead to a rethink of
current guidance for diagnosing suspected heart disease. This means
that, in the future, doctors may have this additional option to
help them safely and accurately diagnose heart
disease.
The study was funded by the BHF and published in
The Lancet.